An observational study in Brugada Syndrome, sponsored by Chulalongkorn University. Recruiting at 11 sites in Thailand. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Chulalongkorn University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Brugada syndrome (BrS) is the leading cause of sudden death in young Asian adults including Thailand. This syndrome may be hereditary and involve mutations in certain genes. Aim of the study is to identify the relationship between genetic variants and the diagnosis/clinical severity of patients with BrS.
This cohort study recruits BrS patients with confirmed Brugada type 1 ECG and healthy volunteers in Thailand. Data collection consists of demographic, clinical data, ECG and blood sample for genetic studies. Genotyping was done by whole genome sequencing and SNP array then compared between cases and controls. Each BrS patient will be followed up prospectively for symptoms and AICD shock. Subsequently, the study will analyze relationship between genetic variants and clinical data against clinical severity of BrS patients.
53 studies on the registry are indexed under Brugada Syndrome; 19 are open to participants now.
This study's planned enrollment of 750 is above the median of 155 across 34 observational studies indexed under Brugada Syndrome.
Browse Brugada Syndrome studies →Chulalongkorn University is the lead sponsor of 323 studies on the registry; 67 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Thai Brugada syndrome patients and healthy volunteers
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Thai patients with diagnosed Brugada syndrome by confirmed Brugada type 1 ECG.
Healthy volunteers without Brugada marker from ECG.
Relationship between genetic variants and Brugada syndrome (Brugada syndrome phenotype)
Case-Control study of genetic variants in BrS cases vs controls. Genetic study was done by whole genome sequencing and SNP array. Association analysis assessed by polygenic risk score and regression coefficients.
Time frame: 7 years
Natural history of Brugada syndrome (survival from arrhythmic events)
Cohort study to followed up BrS patients with or with arrhythmic events which assessed by survival curve analysis.
Time frame: 7 years
Epidemiology of Brugada syndrome
To study prevalence of Brugada syndrome in Thailand.
Time frame: 7 years
Plan to share: Yes — Medical journals, abstract submissions and results database
Started Jan 2016 (actual). Primary completion is estimated for Jan 2031, 179 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: primary completion Jan 2021 → Jan 2031 and completion Jan 2023 → Jan 2031.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.